CD95 system counter attack and prognostic impact.
Debatin
Klaus-Michael
KM
D000818:Animals; D014408:Biomarkers, Tumor / Q000032:analysis / Q000276:immunology*; D053222:Fas Ligand Protein; D006801:Humans; D008562:Membrane Glycoproteins / Q000032:analysis / Q000276:immunology*; D009363:Neoplasm Proteins / Q000032:analysis / Q000276:immunology*; D009369:Neoplasms / Q000175:diagnosis* / Q000276:immunology*; D011379:Prognosis; D048069:Tumor Necrosis Factors / Q000032:analysis / Q000276:immunology*; D019014:fas Receptor / Q000032:analysis / Q000276:immunology*
D014408:Biomarkers, Tumor; C505661:FASLG protein, human; D053222:Fas Ligand Protein; D008562:Membrane Glycoproteins; D009363:Neoplasm Proteins; D048069:Tumor Necrosis Factors; D019014:fas Receptor